EGLN2 and chronic kidney disease: For example, Muratsu-Ikeda et al. demonstrated that miR-205 plays a protective role against oxidative stress in HK2 cells via suppressing egl-9 family hypoxia inducible factor 2 (EGLN2), subsequently reducing ROS levels and presenting a potential therapeutic target in AKI and CKD [262].